Insight

Key Takeaways from Asembia’s AXS24 Summit

Watch the videos below to hear CoverMyMeds leaders share the conversations that broke barriers at Asembia's Specialty Pharmacy Summit, AXS24. Topics include actionable data, interoperability, specialty pipeline, AI and commercialization.

May 10, 202410 min
  • Share on LinkedIn
  • Share on X
  • Share on Facebook
Asembia 2024 Key Takeaways graphic with the CoverMyMeds logo in the upper left corner

Asembia's Specialty Pharmacy Summit, AXS24, was a whirlwind of meetings and educational sessions, providing a platform for industry thought leaders and executives to exchange valuable insights. There is a lot to take away from the conference to help stay ahead in a dynamic market.

In our daily recaps from the event, we highlighted key sessions focused on a wide range of topics related to the specialty pipeline, trends in patient support programs, the complexities of the regulatory landscape and more.

Additionally, in the following video series, our leaders share their insights on key industry trends discussed at AXS24, including the:

  • Power of actionable data in improving medication access,
  • Demand for interoperability,
  • Promising innovations in the pipeline,
  • Growing influence of AI (artificial intelligence) in healthcare, and
  • Increasing complexity of commercialization.

Read the blogs and watch the videos to better understand some of the key trends and challenges shaping the future of the specialty pharmacy industry.

Actionable Data

0:00
Kevin Kettler, President, CoverMyMeds

Interoperability

0:00
John Beardsley, Senior Vice President, Corporate Strategy & Business Development

Specialty Pipeline

0:00
Clay Courville, Chief Product Officer, CoverMyMeds

Artificial Intelligence

0:00
Chrissy Hand, Chief Operating Officer, CoverMyMeds

Commercialization

0:00
Shawn Seamans, Chief Commercial Officer, CoverMyMeds

Catch up on the AXS24 sessions you missed by reading:

Keep up with the latest industry news and insights by subscribing to our Insights newsletter.

Chat with support